General Health EducationJin Shin Jyutsu®-Based Hand Application
General Health Education: Participants assigned to the control group will receive standard verbal health education related to general health during perimenopause. The content includes information on common perimenopausal changes and general lifestyle recommendations. No Jin Shin Jyutsu® techniques, relaxation exercises, or structured coping interventions are included.
Jin Shin Jyutsu®-Based Hand Application: Participants assigned to the experimental arm will receive a Jin Shin Jyutsu®-based hand application program guided by the Transactional Model of Stress and Coping. During the initial session, participants will receive a structured face-to-face training lasting approximately 30-40 minutes, including verbal instruction, visual materials, and a practical demonstration of the hand application techniques.
Participants will be instructed to practice the Jin Shin Jyutsu® hand application daily for at least 15 minutes over a 14-day period. The intervention is designed as a self-care-based supportive approach and does not involve medical treatment, physical manipulation, or pharmacological therapy.
To support adherence, participants will receive written instructions, a daily self-monitoring log, and brief reminder messages via WhatsApp® during the intervention period. No additional therapeutic techniques or relaxation interventions will be provided.
Study summary
This study aims to evaluate the effect of Jin Shin Jyutsu-based hand application guided by the Transactional Model of Stress and Coping on quality of life and psychosocial status in perimenopausal women. Participants will receive a structured hand application intervention over a defined period. Outcomes related to quality of life and psychosocial well-being will be assessed before and after the intervention.
Eligibility
Sex
FEMALE
Min age
40 Years
Max age
54 Years
Healthy volunteers
Accepted
Inclusion Criteria:
* Women aged 40-54 years
* Being in the perimenopausal period according to the STRAW+10 criteria
* Being literate
Exclusion Criteria:
* Use of hormone replacement therapy
* Regular use of complementary or alternative therapy
* History of diagnosed psychiatric disorders
* Inability to comply with the intervention protocol
Primary outcome measure(s)
Descriptive Information Form — Day 1 (Baseline, Pre-Intervention) This is a 24-question form designed by researchers to determine participants' sociodemographic characteristics, women's health status, general health knowledge, lifestyle, and support levels.
Coping Strategies — Day 1 (Baseline, before intervention for intervention groups, before routine assessment for control group) and Day 14 (Post-intervention for intervention groups, after routine assessment for active comparator). The Stress Coping Methods Scale (SBÇYÖ) is a self-report questionnaire assessing active and cognitive coping strategies used by adults when facing stressful situations. The scale consists of 21 items rated on a 5-point Likert scale (1-5) and includes five subdomains: logical analysis, positive reappraisal, problem solving, seeking professional support, and seeking environmental support. Total and subscale scores increase as the corresponding coping strategy is used more frequently. Higher scores indicate greater use of the specified coping strategy.
Menopause-Specific Quality of Life — Day 1 (Baseline, before intervention for intervention groups, before routine assessment for control group) and Day 14 (Post-intervention for intervention groups, after routine assessment for active comparator). The Menopause-Specific Quality of Life Questionnaire - II (MENQOL / MÖYKÖ-II) is a validated self-report instrument developed to assess the presence and severity of menopause-related symptoms and their impact on quality of life across vasomotor, psychosocial, physical, and sexual domains.
The scale consists of 29 items. For each item, participants indicate whether the symptom is present; if present, the level of discomfort is rated. Item scores are converted to a 1-8 scoring system. The total score ranges from 29 to 232, with higher scores indicating worse quality of life and greater negative impact of menopausal symptoms.
Distress Thermometer — Day 1 (Baseline, before intervention for intervention groups, before routine assessment for control group) and Day 14 (Post-intervention for intervention groups, after routine assessment for active comparator). The Distress Thermometer is a single-item visual analog scale designed to rapidly assess overall psychological distress. Participants rate their distress level on a scale ranging from 0 (no distress) to 10 (extreme distress).
Higher scores indicate higher levels of psychological distress. In this study, the problem list accompanying the Distress Thermometer is not used.
Depression, Anxiety, and Stress — Day 1 (Baseline, before intervention for intervention groups, before routine assessment for control group) and Day 14 (Post-intervention for intervention groups, after routine assessment for active comparator). The Depression Anxiety Stress Scales-21 (DASS-21) is a self-report questionnaire assessing depression, anxiety, and stress symptoms over the past week. It consists of 21 items, with three subscales of seven items each.
Items are rated on a 4-point Likert scale (0-3). Subscale scores range from 0 to 42 after standard score conversion. Higher scores indicate greater levels of depression, anxiety, and stress, reflecting worse psychological outcomes.
Daily Practice Schedule for JSJ®-Based Hand Application — The intervention group will complete this chart for 14 days. This chart, developed by the researchers, is designed for participants to regularly record their daily practices for 14 days. The chart includes the day, total time, whether the five-finger grip was completed, and notes. This chart will be used to monitor the level of adherence to the intervention and the frequency of problem-focused coping actions.
Trial sites (1)
Facility
City
Region
Status
Istanbul Provincial Directorate of Health - Family Health Centers
Istanbul
Turkey (Türkiye)
More Istanbul University - Cerrahpasa trials in Turkey
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time.